<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC7128376/results/search/drug/results.xml">
  <result pre="2003; Guerrero et al., 2013; Markland et al., 2000) 2." exact="Ritonavir" post="and lopinavir SARS, MERS (Chu et al., 2004) 3."/>
  <result pre="et al., 2013; Markland et al., 2000) 2. Ritonavir and" exact="lopinavir" post="SARS, MERS (Chu et al., 2004) 3. Ribavirin RSV"/>
  <result pre="Ritonavir and lopinavir SARS, MERS (Chu et al., 2004) 3." exact="Ribavirin" post="RSV and RSV pneumonia (Lewinsohn et al., 1996; McIntosh"/>
  <result pre="1984) 4. Reverse transcriptase inhibitors: zidovudine, didanosine, zalcitabine, stavudine, lamivudine," exact="abacavir" post="and emtricitabine. SARS (De Clercq, 2007) 5. Nucleotide reverse"/>
  <result pre="7. Protease Inhibitors (PIs): saquinavir, ritonavir, indinavir, nelfinavir, amprenavir, lopinavir," exact="atazanavir" post="and fosamprenavir. SARS De Clercq, 2007 8. Fusion inhibitor:"/>
  <result pre="and fosamprenavir. SARS De Clercq, 2007 8. Fusion inhibitor: enfuvirtide." exact="Lamivudine" post="and adefovir dipivoxil. SARS De Clercq, 2007 9. Umifenovir"/>
  <result pre="20. Lopinavir COVID-19, SARS, MERS Yao et al., 2020 21." exact="Alcohol" post="Vaporization or Nebulization Inhalation Therapy COVID-19 (Cao, 2020) 22."/>
  <result pre="Alcohol Vaporization or Nebulization Inhalation Therapy COVID-19 (Cao, 2020) 22." exact="Chloroquine" post="SARS, Human Coronavirus OC43. (Keyaerts et al., 2009, Keyaerts"/>
  <result pre="COVID-19 (Richardson et al., 2020; Stebbing et al., 2020) 26." exact="Ruxolitinib" post="COVID-19 (Stebbing et al., 2020) 27. Saquinavir SARS and"/>
  <result pre="al., 2020) 26. Ruxolitinib COVID-19 (Stebbing et al., 2020) 27." exact="Saquinavir" post="SARS and Feline Coronavirus (Blanchard et al., 2004; Comper,"/>
  <result pre="SARS and COVID-19 (Contini, 2020; Tan et al., 2004) 29." exact="Carfilzomib" post="COVID-19 (Wang, 2020) 30. Oseltamivir COVID-19 (Haagmans et al.,"/>
  <result pre="Lu, 2020) 31. Azvudine COVID-19 (Hu et al., 2020) 32." exact="Baloxavir marboxil" post="COVID-19 (Li and Clercq, 2020) 33. Thymosin α1 MERS"/>
  <result pre="2020) 33. Thymosin α1 MERS (Leyva-Grado and Behzadi, 2019) 34." exact="Methylprednisolone" post="SARS, MERS (Kim et al., 2016; Que et al.,"/>
  <result pre="Respiratory Syncytial Virus, ARVI - Acute respiratory viral infections. 10.1" exact="Ribavirin" post="Ribavirin is also a broad-spectrum drug whose therapeutic potential"/>
  <result pre="Syncytial Virus, ARVI - Acute respiratory viral infections. 10.1 Ribavirin" exact="Ribavirin" post="is also a broad-spectrum drug whose therapeutic potential was"/>
  <result pre="by the FDA, competes for the active site of RdRp." exact="Ribavirin" post="scored 109.5 μM of half maximal concentration against SARS-CoV-2"/>
  <result pre="μM of half maximal concentration against SARS-CoV-2 (Elfiky, 2020). 10.2" exact="Sofosbuvir" post="This drug is also an FDA approved drug against"/>
  <result pre="2020b). 10.4 Remidesivir (anti-viral peptide) This particular drug is an" exact="adenosine" post="nucleotide analog, which was used in treatments against Ebola,"/>
  <result pre="2020a, Wang et al., 2020b, Wang et al., 2020c). 10.5" exact="Chloroquine" post="This drug, classified as an anti-malarial drug, has shown"/>
  <result pre="the treatment of avian influenza A (Yan et al., 2013)." exact="Chloroquine" post="also has shown to have anti-viral as well as"/>
  <result pre="Treatment Patients With COVID-19 1.Carrimycin2. Lopinavir/ritonavir tablets or Arbidol or" exact="Chloroquine" post="phosphate Not yet recruiting – 6. Efficacy and Safety"/>
  <result pre="recruiting – 6. Efficacy and Safety of Corticosteroids in COVID-19" exact="Methylprednisolone" post="Recruiting 1. Hubei province hospital of integrated Chinese &amp;amp;"/>
  <result pre="2019-nCoV Remdesivir RCT Remdesivir Recruiting Bin CaoBeijing, Beijing, China 10." exact="Nitric Oxide" post="Gas Inhalation for Severe Acute Respiratory Syndrome in COVID-19."/>
  <result pre="Oxide Gas Inhalation for Severe Acute Respiratory Syndrome in COVID-19." exact="Nitric Oxide" post="Gas Not yet recruiting – 11. Efficacy and Safety"/>
  <result pre="for Novel CoronavirusCritically Ill Patients With Severe Acute Respiratory Failure" exact="Methylprednisolone" post="Recruiting Medical ICU,Peking Union Medical College HospitalBeijing, Beijing, China"/>
  <result pre="Medical ICU,Peking Union Medical College HospitalBeijing, Beijing, China 15. Lopinavir/Ritonavir," exact="Ribavirin" post="and IFN-beta Combination for nCoV Treatment 1. Lopinavir/ritonavir2. Ribavirin3."/>
  <result pre="Kong, Queen Mary HospitalHong Kong, Hong Kong 16. Efficacy of" exact="Chloroquine" post="and Lopinavir/Ritonavir in mild/general novel coronavirus (CoVID-19) infections: a"/>
  <result pre="Sun Yat-Sen University 17. A study for the efficacy of" exact="hydroxychloroquine" post="for mild and moderate COVID-19 infectious diseases Hydroxychloroquine –"/>
  <result pre="efficacy of hydroxychloroquine for mild and moderate COVID-19 infectious diseases" exact="Hydroxychloroquine" post="– The Second Affiliated Hospital of Chongqing Medical University"/>
  <result pre="randomized, open-label, parallel controlled trial for the preventive effect of" exact="hydroxychloroquine" post="on medical personnel after exposure to COVID-19 Hydroxychloroquine –"/>
  <result pre="effect of hydroxychloroquine on medical personnel after exposure to COVID-19" exact="Hydroxychloroquine" post="– Renmin Hospital of Wuhan University 19. The efficacy"/>
  <result pre="University 20. A prospective clinical study for recombinant human interferon" exact="alpha" post="1b spray in the prevention of novel coronavirus (COVID-19)"/>
  <result pre="(COVID-19) infection in highly exposed medical staffs. recombinant human interferon" exact="alpha" post="1b – Chinese PLA General Hospital 21. A Pilot"/>
  <result pre="Infectious Disease, Wuhan, Hubei, China 22. Comparison of Lopinavir/Ritonavir or" exact="Hydroxychloroquine" post="in Patients With Mild Coronavirus Disease (COVID-19) 1.Lopinavir/ritonavir 2.Hydroxychloroquine"/>
  <result pre="Korea, Republic of Korea 23. The Efficacy and Safety of" exact="Thalidomide" post="Combined With Low-dose Hormones in the Treatment of Severe"/>
  <result pre="Combined With Low-dose Hormones in the Treatment of Severe COVID-19" exact="Thalidomide" post="Not yet recruiting – 24. Various Combination of Protease"/>
  <result pre="Trial Oral Not yet recruiting Subsai Kongsaengdao, Bangkok, Thailand 25." exact="Chloroquine" post="Prevention of Coronavirus Disease (COVID-19) in the Healthcare Setting"/>
  <result pre="Chloroquine Prevention of Coronavirus Disease (COVID-19) in the Healthcare Setting" exact="Chloroquine" post="Not yet recruiting – 26. Favipiravir Combined With Tocilizumab"/>
  <result pre="Minnesota, United States 30. Evaluation of Ganovo (Danoprevir) Combined With" exact="Ritonavir" post="in the Treatment of Novel Coronavirus Infection Ganovo with"/>
  <result pre="Ritonavir in the Treatment of Novel Coronavirus Infection Ganovo with" exact="ritonavir" post="+/-Interferon Recruiting The Ninth Hospital of NanchangNanchang, Jiangxi, China"/>
  <result pre="GS-5734™) Remdesivir Initiated – 33. Norwegian Coronavirus Disease 2019 Study" exact="Hydroxychloroquine" post="Sulfate Not yet recruiting – 34. Post-exposure Prophylaxis for"/>
  <result pre="Sulfate Not yet recruiting – 34. Post-exposure Prophylaxis for SARS-Coronavirus-2" exact="Hydroxychloroquine" post="Recruiting University of Minnesota, Minneapolis, Minnesota, United States 35."/>
  <result pre="Minneapolis, Minnesota, United States 35. The efficacy and safety of" exact="pirfenidone" post="capsules in the treatment of severe new coronavirus pneumonia"/>
  <result pre="multiple effects on virus replication and propagation. Molecular basis of" exact="ribavirin" post="resistanceCurr. Opin. Virol.82014101510.1016/j.coviro.2014.04.01124846716 BeckB.R.ShinB.ChoiY.ParkS.KangK.Predicting commercially availableantiviral drugs that may"/>
  <result pre="periodontitis and immune-mediated inflammatory diseasesInt. J. Mol. Sci.202019339410.3390/ijms20143394 CaoY.Suggestion Using" exact="Alcohol" post="Vaporization or Nebulization Inhalation Therapy for Pneumonitis Caused by"/>
  <result pre="and with clinical specimensJ. Clin. Microbiol.202010.1128/JCM.00310-20 CheemaS.U.R.RehmanM.S.HussainG.CheemaS.S.GilaniN.Efficacy and tolerability of" exact="sofosbuvir" post="and daclatasvir for treatment of hepatitis C genotype 1"/>
  <result pre="clinical specimensJ. Clin. Microbiol.202010.1128/JCM.00310-20 CheemaS.U.R.RehmanM.S.HussainG.CheemaS.S.GilaniN.Efficacy and tolerability of sofosbuvir and" exact="daclatasvir" post="for treatment of hepatitis C genotype 1 &amp;amp; 3"/>
  <result pre="fusionJ. Virol.8220082883289410.1128/JVI.01805-0718199653 HsiehL.E.LinC.N.SuB.L.JanT.R.ChenC.M.WangC.H.LinD.S.LinC.T.ChuehL.L.Synergistic antiviral effect of Galanthus nivalis agglutinin and" exact="nelfinavir" post="against feline coronavirusAntivir. Res.882010253010.1016/j.antiviral.2010.06.01020603153 HuF.JiangJ.YinP.Prediction of Potential Commercially Inhibitors"/>
  <result pre="in the viral replication cycleAntivir. Res.75200717918710.1016/j.antiviral.2007.03.00317428553 KeyaertsE.LiS.VijgenL.RysmanE.VerbeeckJ.Van RanstM.MaesP.Antiviral activity of" exact="chloroquine" post="against human coronavirus OC43 infection in newborn miceAntimicrob. Agents"/>
  <result pre="disease (COVID-19) infectionJ. Inf. Secur.202010.1016/j.jinf.2020.03.016 LewinsohnD.M.BowdenR.A.MattsonD.CrawfordS.W.Phase I study of intravenous" exact="ribavirin" post="treatment of respiratory syncytial virus pneumonia after marrow transplantationAntimicrob."/>
  <result pre="activity of the IMP dehydrogenase inhibitor VX-497: a comparison with" exact="ribavirin" post="and demonstration of antiviral additivity with alpha interferonAntimicrob. Agents"/>
  <result pre="a comparison with ribavirin and demonstration of antiviral additivity with" exact="alpha" post="interferonAntimicrob. Agents Chemother.44200085986610.1128/aac.44.4.859-866.200010722482 MatsudaK.ParkC.SundenY.KimuraT.OchiaiK.KidaH.UmemuraT.The vagus nerve is one route"/>
  <result pre="McIntoshK.KurachekS.C.CairnsL.M.BurnsJ.C.GoodspeedB.Treatment of respiratory viral infection in an immunodeficient infant with" exact="ribavirin" post="aerosolAm. J, Dis. Child.13819843053086322573 MengelingW.WLM.ADB.AER.Characteristics of a coronavirus (strain"/>
  <result pre="resistance-inducing protein isolated from Clerodendrum inerme Gaertn. Is a polynucleotide:" exact="adenosine" post="glycosidase (ribosome-inactivating protein)FEBS Lett.39619961321348914973 OtakeT.MoriH.MorimotoM.UebaN.SutardjoS.KusumotoI.T.HattoriM.NambaT.Screening of Indonesian plant extracts"/>
  <result pre="with 2019 novel coronavirus–infected pneumonia in Wuhan, ChinaJama32320201061106910.1001/jama.2020.1585 WangM.CaoR.ZhangL.YangX.LiuJ.XuM.ShiZ.HuZ.ZhongW.XiaoG.Remdesivir and" exact="chloroquine" post="effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in"/>
  <result pre="coronavirus SARS-CoV-2Eur. J. Nucl. Med. and Mol. Imaging20201610.1007/s00259-020-04735-9 YanY.ZouZ.SunY.LiX.XuK.-F.WeiY.JinN.JiangC.Anti-malaria drug" exact="chloroquine" post="is highly effective in treating avian influenza A H5N1"/>
  <result pre="the absence of growth factorsBiochem. J.392200513514310.1042/BJ2005069816048439 YaoT.T.QianJ.D.ZhuW.Y.WangY.WangG.Q.A systematic review of" exact="lopinavir" post="therapy for SARS coronavirus and MERS coronavirus-A possible reference"/>
 </snippets>
</snippetsTree>
